Market Size & Trends
The North America and Europe intravenous infusion pumps market size was valued at USD 4.45 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2030. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.
There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.
Regulatory approvals of advanced infusion pump technologies are a key market driver for the intravenous infusion pump market, improving patient safety, efficiency, and connectivity in healthcare settings. For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ Safety Software, expanding its Novum IQ Infusion Platform. This integrated system, which includes both large volume and syringe pumps, allows clinicians to use a single, connected platform across multiple care settings, enhancing workflow efficiency and reducing medication errors. As hospitals increasingly adopt smart, interoperable infusion technologies, demand for next-generation IV pumps is expected to grow significantly.
North America And Europe Intravenous Infusion Pumps Market Report Segmentation
This report forecasts revenue growth at regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Ambulatory Infusion Pumps
- Patient-Controlled Analgesia Infusion Pumps
- Implantable Infusion Pumps
- Others
- Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Chemotherapy
- Diabetes
- Gastroenterology
- Analgesia/Pain Management
- Pediatrics/Neonatology
- Hematology
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Homecare
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Canada
- Europe
Germany
France
Italy
Spain
Denmark
Sweden
Norway
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Disease Indication
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecast timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Segment
- 2.2.2. Disease Indication Segment
- 2.2.3. End-use Segment
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
- Chapter 3. North America and Europe Intravenous Infusion Pumps Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of chronic diseases
- 3.2.1.2. Technological advancements in infusion pumps
- 3.2.1.3. Rising demand for ambulatory infusion pumps
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lack of reimbursement
- 3.2.2.2. Increasing product recalls
- 3.3. North America and Europe Intravenous Infusion Pumps Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. North America and Europe Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis
- 4.1. North America and Europe Intravenous Infusion Pumps Market: Product Dashboard
- 4.2. North America and Europe Intravenous Infusion Pumps Market: Product Movement Analysis
- 4.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Volumetric Infusion Pumps
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Syringe Infusion Pumps
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.6. Ambulatory Infusion Pumps
- 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.7. Patient-Controlled Analgesia Infusion Pumps
- 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.8. Implantable Infusion Pumps
- 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.9. Others
- 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
- 5.1. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Dashboard
- 5.2. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
- 5.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
- 5.4. Chemotherapy
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Diabetes
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Gastroenterology
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.7. Analgesia/Pain Management
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.8. Pediatrics/Neonatology
- 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.9. Hematology
- 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.10. Others
- 5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. North America and Europe Intravenous Infusion Pumps Market: End-use Estimates & Trend Analysis
- 6.1. North America and Europe Intravenous Infusion Pumps Market: End-use Dashboard
- 6.2. North America and Europe Intravenous Infusion Pumps Market: End-use Movement Analysis
- 6.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Homecare
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. North America and Europe Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Disease Indication, and End-use
- 7.1. North America and Europe Intravenous Infusion Pumps Market: Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.9. Denmark
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework/ reimbursement structure
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2024
- 8.3.4. Baxter
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. End-use benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. B. Braun Melsungen AG
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. End-use benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Fresenius Kabi AG
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. End-use benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. ICU Medical, Inc. (Smiths Medical)
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. End-use benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Micrel Medical Devices SA
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. End-use benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Boston Scientific Corporation
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. End-use benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. BD
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. End-use benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Terumo Corporation
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. End-use benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. End-use benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Moog Inc.
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. End-use benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. IRadimed Corporation
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. End-use benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. CODAN Companies
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. End-use benchmarking
- 8.3.15.4. Strategic initiatives
- 8.3.16. Arcomed
- 8.3.16.1. Company overview
- 8.3.16.2. Financial performance
- 8.3.16.3. End-use benchmarking
- 8.3.16.4. Strategic initiatives
Loading...
In this report,
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook